AI Verdict
JNJ has stronger fundamentals based on our AI analysis.
CVS vs JNJ Fundamental Comparison
| Metric | CVS | JNJ |
|---|---|---|
| Revenue | $402.1B | $94.2B |
| Net Income | $1.8B | $26.8B |
| Net Margin | 0.4% | 28.5% |
| ROE | 2.4% | 32.9% |
| ROA | 0.7% | 13.5% |
| Current Ratio | 0.84x | 1.03x |
| Debt/Equity | 0.85x | 0.51x |
| EPS | $1.39 | $11.03 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
CVS vs JNJ: Frequently Asked Questions
Is CVS or JNJ a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), JNJ has stronger fundamentals. CVS is rated HOLD (70% confidence) while JNJ is rated BUY (86% confidence). This is not investment advice.
How does CVS compare to JNJ fundamentally?
CVS HEALTH Corp has ROE of 2.4% vs JOHNSON & JOHNSON's 32.9%. Net margins are 0.4% vs 28.5% respectively.
Which stock pays higher dividends, CVS or JNJ?
CVS has a dividend yield of N/A or no dividend while JNJ has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in CVS or JNJ for long term?
For long-term investing, consider that CVS has HOLD rating with 70% confidence, while JNJ has BUY rating with 86% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about CVS vs JNJ?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For CVS vs JNJ, the AI consensus favors JNJ based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.